4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer

Estrogen receptor (ER) positive tumors represent the majority of breast malignancies, and are effectively treated with hormonal therapies, such as tamoxifen. However, in the recurrent disease resistance to tamoxifen therapy is common and a major cause of death. In recent years, in‐depth proteome ana...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: De Marchi, Tommaso, Liu, Ning Qing, Stingl, Cristoph, Timmermans, Mieke A., Smid, Marcel, Look, Maxime P., Tjoa, Mila, Braakman, Rene B.H., Opdam, Mark, Linn, Sabine C., Sweep, Fred C.G.J., Span, Paul N., Kliffen, Mike, Luider, Theo M., Foekens, John A., Martens, John W.M., Umar, Arzu
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528925/
https://ncbi.nlm.nih.gov/pubmed/26285647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.07.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados